Citation Impact
Citing Papers
Myeloid Progenitor Cells in the Premetastatic Lung Promote Metastases by Inducing Mesenchymal to Epithelial Transition
2012
Different Tumor Microenvironments Contain Functionally Distinct Subsets of Macrophages Derived from Ly6C(high) Monocytes
2010
Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy
2011
Aptamer-Mediated Blockade of IL4Rα Triggers Apoptosis of MDSCs and Limits Tumor Progression
2012
Modulators of Arginine Metabolism Do Not Impact on Peripheral T-Cell Tolerance and Disease Progression in a Model of Spontaneous Prostate Cancer
2011
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer
2007 StandoutNobel
Inhibition of Tumor-Derived Prostaglandin-E2 Blocks the Induction of Myeloid-Derived Suppressor Cells and Recovers Natural Killer Cell Activity
2014
Anti-inflammatory Triterpenoid Blocks Immune Suppressive Function of MDSCs and Improves Immune Response in Cancer
2010
Aire-Dependent Thymic Development of Tumor-Associated Regulatory T Cells
2013 StandoutScienceNobel
Macrophage Migration Inhibitory Factor Promotes Tumor Growth and Metastasis by Inducing Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
2012
The P1 family: a new class of nuclear mammalian proteins related to the yeast Mem replication proteins
1993
Alternative Activation Is an Innate Response to Injury That Requires CD4+ T Cells to be Sustained during Chronic Infection
2007 StandoutNobel
Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
2008
Stat6 Signaling Suppresses VLA-4 Expression by CD8+ T Cells and Limits Their Ability to Infiltrate Tumor Lesions In Vivo
2008
IL4Rα+ Myeloid-Derived Suppressor Cell Expansion in Cancer Patients
2009
Mechanism Regulating Reactive Oxygen Species in Tumor-Induced Myeloid-Derived Suppressor Cells
2009
Requirement for Interactions of Natural Killer T Cells and Myeloid-Derived Suppressor Cells for Transplantation Tolerance
2014
Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13
2011
Hallmarks of Cancer: The Next Generation
2011 Standout
Engineered receptors for soluble cellular communication and disease sensing
2024 StandoutNatureNobel
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Inflammation and cancer
2002 StandoutNature
Altered macrophage differentiation and immune dysfunction in tumor development
2007
p25rum1 orders S phase and mitosis by acting as an inhibitor of the p34cdc2 mitotic kinase
1995 StandoutNobel
Myeloid-derived suppressor cell heterogeneity and subset definition
2010
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
2016 Standout
Combining immunotherapy and targeted therapies in cancer treatment
2012
miR-142-3p Prevents Macrophage Differentiation during Cancer-Induced Myelopoiesis
2013
Alarmins: awaiting a clinical response
2012
Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer
2013
Hierarchy of immunosuppressive strength among myeloid‐derived suppressor cell subsets is determined by GM‐CSF
2009
The role of myeloid cells in the promotion of tumour angiogenesis
2008
Regulatory T Cells and Immune Tolerance
2008 StandoutNobel
Components and Dynamics of DNA Replication Complexes in S. cerevisiae: Redistribution of MCM Proteins and Cdc45p during S Phase
1997
Coordinated regulation of myeloid cells by tumours
2012 Standout
IL‐1β regulates a novel myeloid‐derived suppressor cell subset that impairs NK cell development and function
2010
The nuclear envelope prevents reinitiation of replication by regulating the binding of MCM3 to chromatin in Xenopus egg extracts
1995
p65cdc18 Plays a major role controlling the initiation of DNA replication in fission yeast
1995 StandoutNobel
Gene Ontology: tool for the unification of biology
2000 Standout
Cancer immunoediting from immune surveillance to immune escape
2007
Myeloid-derived suppressor cells as regulators of the immune system
2009 Standout
A Long Twentieth Century of the Cell Cycle and Beyond
2000 StandoutNobel
Isolation and Characterization of Various Complexes of the Minichromosome Maintenance Proteins of Schizosaccharomyces pombe
2000
hCDC47, a Human Member of the MCM Family
1996
RORC1 Regulates Tumor-Promoting “Emergency” Granulo-Monocytopoiesis
2015
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Corrupt policemen: inflammatory cells promote tumor angiogenesis
2008
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Regulatory T cells and cancer
2007
Once and only once upon a time: specifying and regulating origins of DNA replication in eukaryotic cells.
1996
Purification of an MCM-containing complex as a component of the DNA replication licensing system
1995 Nature
Mechanisms and functional significance of tumour-induced dendritic-cell defects
2004
Chronic immune activation and inflammation in the pathogenesis of aids and cancer
2002
Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice
2011
Taking dendritic cells into medicine
2007 StandoutNatureNobel
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
2015 Standout
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
2010 Standout
Stem cells in tumor angiogenesis
2010
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
STATs in cancer inflammation and immunity: a leading role for STAT3
2009 Standout
Alternative Activation of Macrophages: Mechanism and Functions
2010 Standout
Pooled Knockin Targeting for Genome Engineering of Cellular Immunotherapies
2020
Elusive Identities and Overlapping Phenotypes of Proangiogenic Myeloid Cells in Tumors
2010
HIF1α Induces the Recruitment of Bone Marrow-Derived Vascular Modulatory Cells to Regulate Tumor Angiogenesis and Invasion
2008
Microenvironmental regulation of metastasis
2008 Standout
The Cdt1 protein is required to license DNA for replication in fission yeast
2000 StandoutNatureNobel
The fission yeast cdc18+ gene product couples S phase to START and mitosis
1993 StandoutNobel
Stat3 mediates myeloid cell–dependent tumor angiogenesis in mice
2008
Protective and pathogenic functions of macrophage subsets
2011 Standout
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
2012 StandoutNatureNobel
Slow Disease Progression in a C57BL/6 Pten-Deficient Mouse Model of Prostate Cancer
2011
Homeodomain-DNA recognition
1994 StandoutNobel
Fission yeastcdc21+belongs to a family of proteins involved in an early step of chromosome replication
1992
History of myeloid-derived suppressor cells
2013
Cell cycle control of DNA synthesis in budding yeast
1992
Cancer-related inflammation
2008 StandoutNature
The yeast cell-type-specific repressor α2 acts cooperatively with a non-cell-type-specific protein
1988
Hypoxia Promotes Tumor Growth in Linking Angiogenesis to Immune Escape
2012
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Modes of resistance to anti-angiogenic therapy
2008 Standout
Interaction between the Origin Recognition Complex and the Replication Licensing Systemin Xenopus
1996
Inflammation, inflammatory cells and angiogenesis: decisions and indecisions
2007
tea1 and the Microtubular Cytoskeleton Are Important for Generating Global Spatial Order within the Fission Yeast Cell
1997 StandoutNobel
Tumors as Organs: Complex Tissues that Interface with the Entire Organism
2010
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
2009 Standout
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
2016 Standout
Universal control mechanism regulating onset of M-phase
1990 StandoutNatureNobel
Defining and using immune archetypes to classify and treat cancer
2023
Granulocytic myeloid-derived suppressor cells are cryosensitive and their frequency does not correlate with serum concentrations of colony-stimulating factors in head and neck cancer
2012
Expression of Cationic Amino Acid Transporter 2 Is Required for Myeloid-Derived Suppressor Cell–Mediated Control of T Cell Immunity
2015
The fission yeast cdc19+ gene encodes a member of the MCM family of replication proteins
1994 StandoutNobel
Identification, purification, and cloning of a polypeptide (PRTF/GRM) that binds to mating-specific promoter elements in yeast.
1990
Checkpoints: Controls That Ensure the Order of Cell Cycle Events
1989 StandoutScienceNobel
Fission yeast genes nda1+ and nda4+, mutations of which lead to S-phase block, chromatin alteration and Ca2+ suppression, are members of the CDC46/MCM2 family.
1993
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
2016 Standout
Anti‐IL ‐6 receptor mA b eliminates myeloid‐derived suppressor cells and inhibits tumor growth by enhancing T ‐cell responses
2012
Purification and characterization of human DNA damage checkpoint Rad complexes
2001 StandoutNobel
GVHD-associated, inflammasome-mediated loss of function in adoptively transferred myeloid-derived suppressor cells
2015
Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages
2015
Tumor immune escape mechanisms: impact of the neuroendocrine system
2006
Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected
2015
ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R–mediated apoptosis
2014
Natural Innate and Adaptive Immunity to Cancer
2011 Standout
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
Circulating immunosuppressive cells of prostate cancer patients before and after radical prostatectomy: Profile comparison
2013
Programmed assembly of 3-dimensional microtissues with defined cellular connectivity
2009 StandoutNobel
Cellular and molecular mechanisms in cancer immune escape: a comprehensive review
2013
Cell Cycle Control of DNA Replication
1996 Science
HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment
2010
Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell–suppressive activity
2008
Myeloid‐derived suppressor cell heterogeneity in human cancers
2014
A protein involved in minichromosome maintenance in yeast binds a transcriptional enhancer conserved in eukaryotes.
1989
Cell cycle-regulated nuclear localization of MCM2 and MCM3, which are required for the initiation of DNA synthesis at chromosomal replication origins in yeast.
1993
MCM Proteins in DNA Replication
1999
S Phase of the Cell Cycle
1989 Science
Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model
2012 StandoutNobel
CDC46/MCM5, a yeast protein whose subcellular localization is cell cycle-regulated, is involved in DNA replication at autonomously replicating sequences.
1992
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
2008 StandoutNobel
Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells
2014
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
SHIP Represses the Generation of IL-3-Induced M2 Macrophages by Inhibiting IL-4 Production from Basophils
2009
Mcm2 and Mcm3, two proteins important for ARS activity, are related in structure and function.
1991
Myeloid-Derived Suppressor Cells in the Development of Lung Cancer
2013
Intratumoral Injection of CpG Oligonucleotides Induces the Differentiation and Reduces the Immunosuppressive Activity of Myeloid-Derived Suppressor Cells
2012
Immunosuppressive Strategies that are Mediated by Tumor Cells
2006
Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host
2007
Yeast chromosome replication and segregation
1988
The ORC1 homolog orp1 in fission yeast plays a key role in regulating onset of S phase.
1996 StandoutNobel
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
A group of interacting yeast DNA replication genes.
1991
Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein
2008
Breast cancer instructs dendritic cells to prime interleukin 13–secreting CD4+ T cells that facilitate tumor development
2007
Cdc6p-dependent loading of Mcm proteins onto pre-replicative chromatin in budding yeast
1997
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
2010 StandoutNobel
The phenotype of the minichromosome maintenance mutant mcm3 is characteristic of mutants defective in DNA replication.
1990
Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis
2013
Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
2014 Standout
Myeloid-Derived Suppressor Cells as a Potential Therapy for Experimental Autoimmune Myasthenia Gravis
2014
Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells
2006
Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment
2014 StandoutNobel
Subpopulations of myeloid‐derived suppressor cells impair T cell responses through independent nitric oxide‐related pathways
2013
Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice
2011
INITIATION OF DNA REPLICATION IN EUKARYOTIC CELLS
1997
THE UBIQUITIN SYSTEM
1998 StandoutNobel
DNA polymerase alpha associated protein P1, a murine homolog of yeast MCM3, changes its intranuclear distribution during the DNA synthetic period.
1994
Fission yeast cdc21, a member of the MCM protein family, is required for onset of S phase and is located in the nucleus throughout the cell cycle.
1996
Works of Pratima Sinha being referenced
HMGB1 Enhances Immune Suppression by Facilitating the Differentiation and Suppressive Activity of Myeloid-Derived Suppressor Cells
2014
Myeloid-Derived Suppressor Cells Inhibit T-Cell Activation by Depleting Cystine and Cysteine
2009
Myeloid-Derived Suppressor Cells Down-Regulate L-Selectin Expression on CD4+ and CD8+ T Cells
2009
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
2009 Standout
Regulating the suppressors: apoptosis and inflammation govern the survival of tumor-induced myeloid-derived suppressor cells (MDSC)
2012
Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression
2012
Induction of Cell Proliferation and Apoptosis: Dependence on the Dose of the Inducer
1999
Proteomic Pathway Analysis Reveals Inflammation Increases Myeloid-Derived Suppressor Cell Resistance to Apoptosis
2010
Signal transducer and activator of transcription 6 (Stat6) and CD1: inhibitors of immunosurveillance against primary tumors and metastatic disease
2004
The mcm2-1 mutation of yeast causes DNA damage with a RAD9 requirement for repair
1995
MCM21 and MCM22, two novel genes of the yeast Saccharomyces cerevisiae are required for chromosome transmission
1999
The mcm2 mutation of yeast affects replication, rather than segregation or amplification of the two micron plasmid
1992
RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis
2008
Tumor immunity: a balancing act between T cell activation, macrophage activation and tumor-induced immune suppression
2005
Proinflammatory S100 Proteins Regulate the Accumulation of Myeloid-Derived Suppressor Cells
2008
Reduction of Myeloid-Derived Suppressor Cells and Induction of M1 Macrophages Facilitate the Rejection of Established Metastatic Disease
2005
Cross-talk among myeloid-derived suppressor cells, macrophages, and tumor cells impacts the inflammatory milieu of solid tumors
2014
Reduced Inflammation in the Tumor Microenvironment Delays the Accumulation of Myeloid-Derived Suppressor Cells and Limits Tumor Progression
2007
Interleukin-13–regulated M2 Macrophages in Combination with Myeloid Suppressor Cells Block Immune Surveillance against Metastasis
2005
MUTANTS OF S. CEREVISIAE DEFECTIVE IN THE MAINTENANCE OF MINICHROMOSOMES
1984
Inflammation Induces Myeloid-Derived Suppressor Cells that Facilitate Tumor Progression
2006
Cross-Talk between Myeloid-Derived Suppressor Cells and Macrophages Subverts Tumor Immunity toward a Type 2 Response
2007
Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell–expressed FasL
2011
Surgical Removal of Primary Tumor Reverses Tumor-Induced Immunosuppression Despite the Presence of Metastatic Disease
2004
A mutant that affects the function of autonomously replicating sequences in yeast
1986
Tumor‐induced myeloid‐derived suppressor cell function is independent of IFN ‐γ and IL ‐4R α
2012
A nonclassical non-Vα14Jα18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance
2005
Prostaglandin E2 Promotes Tumor Progression by Inducing Myeloid-Derived Suppressor Cells
2007
Inflammation enhances myeloid-derived suppressor cell cross-talk by signaling through Toll-like receptor 4
2009